P-571. Exploring the Dengue Vaccination Intention among Adults from Regions with Medium and High Incidence of Dengue in Peru
Abstract Background Among the several interventions to prevent dengue, vaccination has emerged as one of the most promising tools. The TAK-003 vaccine was introduced in Peru in November 2024, targeting children from 10 to 14 years. However, it is expected that this vaccine will be offered to adults...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | inglés |
| Publicado: |
2026
|
| Acceso en línea: | Enlace permanente (DOI o Handle) Enlace permanente (DOI o Handle) |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: P-571. Exploring the Dengue Vaccination Intention among Adults from Regions with Medium and High Incidence of Dengue in Peru
- Factors Associated with Intention to Receive the TAK-003 Dengue Vaccine Among Adults in Endemic Regions of Peru: A Cross-Sectional Study
- Knowledge and Perceptions about Diagnosis, Clinical Management, and Prevention of Dengue Fever among Physicians during the 2023 Outbreak: A Cross-Sectional Study in Peru
- Factors Associated with the Prevalence of Dengue–Leptospirosis Coinfection in Patients Hospitalized for Febrile Syndrome
- COVID-19 and dengue coinfection in Latin America: A systematic review
- Impact of Rising Global Temperatures on Dengue Infection and Serotype Distribution: A Mini Review
- Comportamiento epidemiológico del Dengue, Chikungunya y Zika. Córdoba – Colombia. 2014-2017